Age (years) | Risk group | Detection method | Time from the last negative exam (months) | Type of tumor | Tumor size (cm) | Stage | Grading | Hormonal receptors ER/PgR (%) | Ki67 (%) |
---|---|---|---|---|---|---|---|---|---|
49 | Intermediate | CBE | 10 | Inflammatory | 4* | IV | 3 | 0/0 | nd |
64 | Slightly increased | CBE | 1 | DCI | 0.2° | II | 3 | 90/90 | 10 |
51 | High | CBE | 9§ | LCI | 1.5 | I | 3 | 80/80 | 20 |
45 | Intermediate | CBE | 14 | DCIS∞ | 0.6 | is | 1 | 0/0 | nd |
32• | Slightly increased | CBE+US | 10 | LCI | 2 | III | 3 | 80/30 | 20 |
47 | BRCA+ | CBE+US | 3® | DCI | 1.2 | I | 3 | 0/0 | 60 |
45 | High | CBE+US© | 5 | DCI | 0.7 | I | 3 | 70/80 | 60 |
46 | Intermediate | CBE+US+Mx© | 10 | DCI | 1.6 | II | 3 | 0/0 | 10 |